Serial quantitation of serum core protein and viral RNA of hepatitis C virus after interferon therapy: Increase in viral loads in biochemical responders

American Journal of Gastroenterology

Volumn 92, Issue 8, 1997, Pages 1305-1309

  Yoshioka, Kentaro ^a   Aiyama, T ^b   Iwata, K ^b   Yano, M ^b   Okumura, A ^b   Ishikawa, T ^b   Kakumu, S ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORE PROTEIN; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEPATITIS C; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; VIREMIA;

EID: 0030795242     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 1989;321:1501-6.
2. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.